Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
465 GBX | -0.85% | +9.67% | +27.40% |
04-24 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
04-23 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm trades with high earnings multiples: 25.55 times its 2023 earnings per share.
- The company's enterprise value to sales, at 4.72 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.40% | 153M | - | ||
+0.16% | 75.94B | B | ||
+12.06% | 21.7B | C+ | ||
+27.19% | 12.54B | C+ | ||
+39.83% | 8.36B | C+ | ||
-0.13% | 7.96B | B- | ||
+44.53% | 5.21B | C | ||
-2.16% | 2.96B | C+ | ||
-5.45% | 1.69B | C | ||
+15.14% | 1.29B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AQX Stock
- Ratings Aquis Exchange PLC